MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Year: 1998
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: J H Glick, M L Young, D Harrington, R L Schilsky, T Beck, R Neiman, R I Fisher, B A Peterson, M M Oken
Institution: University of Pennsylvania
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1827683443